Metiprenaline
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Metiprenaline (INN; developmental code name Egyt 402), also known as 3-O-methylisoprenaline, is a bronchodilator which was never marketed.[1][2] It is the 3-O-methyl derivative of isoprenaline (isoproterenol).[1][2]
Other namesEgyt 402; O-Methylisoprenaline; Methylprenaline; 3-Methoxyisoprenaline; MOXA; 3-Methoxyisoproterenol; 3-O-Methylisoprenaline; 3-O-Methylisoproterenol
| Clinical data | |
|---|---|
| Other names | Egyt 402; O-Methylisoprenaline; Methylprenaline; 3-Methoxyisoprenaline; MOXA; 3-Methoxyisoproterenol; 3-O-Methylisoprenaline; 3-O-Methylisoproterenol |
| Drug class | Bronchodilator |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H19NO3 |
| Molar mass | 225.288 g·mol−1 |
| 3D model (JSmol) | |
| |
| |